FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Xavier Thomas

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Eric Jourdan; Bruno Lioure; Isabelle Luquet; Cécile Pautas; Arnaud Pigneux; Claude Preudhomme; Emmanuel Raffoux; Christian Recher; Aline Renneville; Christine Terré; Xavier Thomas; Norbert Vey; Marie C Béné; Céline Berthon; Odile Blanchet; Nicolas Boissel; Claude-Eric Bulabois; Jean-Michel Cayuela; Sylvie Chevret; Pascale Cornillet; Eric Delabesse; Jacques Delaunay; Hervé Dombret; Philippe Guardiola; Norbert Ifrah
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Claude Gardin; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Aline Renneville; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Dominique Bordessoule; Sylvie Castaigne; Karine Celli-Lebras; Sylvie Chevret; Stéphane de Botton; Thierry de Revel; Pierre Fenaux; Nathalie Gachard; Hervé Dombret
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Aline Tanguy-Schmidt; Marie-Christiane Vekemans; Jean-Paul Vernant; Jean-Yves Cahn; Jean-Michel Cayuela; Yves Chalandon; André Delannoy; Hervé Dombret; Martine Escoffre; Sandrine Hayette; Françoise Huguet; Norbert Ifrah; Delphine Réa; Philippe Rousselot; Xavier Thomas
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Xavier Thomas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eric Jourdan; Bruno Lioure; Isabelle Luquet; Cécile Pautas; Arnaud Pigneux; Claude Preudhomme; Emmanuel Raffoux; Christian Recher; Aline Renneville; Christine Terré; Xavier Thomas; Norbert Vey; Marie C Béné; Céline Berthon; Odile Blanchet; Nicolas Boissel; Claude-Eric Bulabois; Jean-Michel Cayuela; Sylvie Chevret; Pascale Cornillet; Eric Delabesse; Jacques Delaunay; Hervé Dombret; Philippe Guardiola; Norbert Ifrah
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Blood 2013;121(12):2213-23.
2013: Claude Gardin; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Aline Renneville; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Dominique Bordessoule; Sylvie Castaigne; Karine Celli-Lebras; Sylvie Chevret; Stéphane de Botton; Thierry de Revel; Pierre Fenaux; Nathalie Gachard; Hervé Dombret
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(3):321-7.
2013: Aline Tanguy-Schmidt; Marie-Christiane Vekemans; Jean-Paul Vernant; Jean-Yves Cahn; Jean-Michel Cayuela; Yves Chalandon; André Delannoy; Hervé Dombret; Martine Escoffre; Sandrine Hayette; Françoise Huguet; Norbert Ifrah; Delphine Réa; Philippe Rousselot; Xavier Thomas
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):150-5.
2012: Pauline Peyrouze; Arnaud Pigneux; Nicolas Pottier; Xavier Thomas; Marie Christine Béné; Céline Berthon; Jean-Yves Cahn; Eric Delabesse; Hervé Dombret; Nathalie Grardel; Soizic Guihard; Norbert Ifrah; Véronique Lhéritier; Elizabeth Macintyre; Meyling Cheok
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
British journal of haematology 2012;159(5):599-602.
2012: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Catherine Cordonnier; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Gérard Socié; Christine Terré; Hervé Dombret
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.
Leukemia research 2012;36(9):1112-8.
2012: Aline Renneville; T de Revel; Christine Terre; Xavier Thomas; Oumedaly Reman; C Berthon; Nicolas Boissel; Dominique Bordessoule; S de Botton; Sylvie Castaigne; Jean-Michel Cayuela; Nathalie Contentin; Hervé Dombret; Pierre Fenaux; Claude Gardin; Sandrine Hayette; N Helevaut; O Nibourel; Cécile Pautas; Claude Preudhomme
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Leukemia 2012;26(6):1247-54.
2012: Giovanna Cannas; Sylvie Castaigne; Hervé Dombret; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Mauricette Michallet; Cécile Pautas; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Stéphane de Botton; Thierry de Revel; Nicolas Boissel; Xavier Thomas
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.
Leukemia & lymphoma 2012;53(6):1068-76.
2012: Cecile Bally; Andre Baruchel; Yves Bertrand; Bruno Cassinat; Christine Chomienne; Herve Dombret; Jehane Fadlallah; Pierre Fenaux; Agnes Guerci; Nadia Idres; Thierry Leblanc; Guy Leverger; Emmanuel Raffoux; Christian Recher; Alain Robert; Miguel Sanz; Xavier Thomas; Norbert Vey; Lionel Adès
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1641-6.
2012: Sylvie Castaigne; Sylvie Chevret; Nathalie Contentin; Noémie de Gunzburg; Thierry de Revel; Hervé Dombret; Pierre Fenaux; Lauris Gastaud; Estelle Henry; Ollivier Legrand; Jean-Pierre Marolleau; Cécile Pautas; Claude Preudhomme; Emmanuel Raffoux; Oumedaly Reman; Philippe Rousselot; Christine Terré; Xavier Thomas; Pascal Turlure; Ahmad Aljijakli; Jean-Noel Bastie; Dominique Bordessoule
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Lancet 2012;379(9825):1508-16.
2012: Sandrine Hayette; Sarah Huet; Laurent Jallades; Jean-Pierre Magaud; Kaddour Chabane; Carole Charlot; Pascale Cornillet-Lefebvre; Sophie Gazzo; Stéphane Morisset; Franck Emmanuel Nicolini; Adriana Plesa; Aline Renneville; Gilles SALLES; Xavier Thomas; Isabelle Tigaud; Mauricette Michallet
High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.
PloS one 2012;7(12):e51527.
2011: Marie-Christine Nicolle; Stéphane Picot; Marie-Antoinette Piens; Mohamad Sobh; Anne Thiebaut; Xavier Thomas; Thomas Bénet; Anne-Lise Bienvenu; Giovanna Cannas; Frédérique de Monbrison; Antoine Duclos; Mauricette Michallet; Franck E Nicolini; Nicolas Voirin; Philippe Vanhems
Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.
Haematologica 2011;96(11):1685-91.
2011: Xavier Thomas; Youcef Chelghoum; Najeeb Fanari; Giovanna Cannas
Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies.
Hematology (Amsterdam, Netherlands) 2011;16(5):278-83.
2011: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Yosr Hicheri; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Christine Terré; Hervé Dombret
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.
Blood 2011;118(7):1754-62.
2011: Xavier Thomas; Isabelle Tigaud; Franck E Nicolini; Giovanna Cannas; Youcef Chelghoum; Sophie Ducastelle; Charles Dumontet; Mohamed Elhamri; Hélène Labussière; Mauricette Michallet
Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
Clinical lymphoma, myeloma & leukemia 2011;11(4):342-9.
2011: Alice Gougounon; Mauricette Michallet; Adriana Plesa; Lauren Rigollet; Halima Abahssain; Youcef Chelghoum; Charles Dumontet; Mohamed Elhamri; Isabelle Tigaud; Xavier Thomas
Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases.
Leukemia research 2011;35(8):1027-31.
2011: Raphael Itzykson; Cécile Pautas; Emmanuel Raffoux; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Sylvie Castaigne; Hervé Dombret; Pierre Fenaux; Claude Gardin
Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria.
Haematologica 2011;96(6):837-44.
2011: Carine Domenech; Xavier Thomas; Sylvie Chabaud; Andre Baruchel; François Gueyffier; Françoise Mazingue; Anne Auvrignon; Selim Corm; Hervé Dombret; Patrice Chevallier; Claire Galambrun; Françoise Huguet; Faezeh Legrand; Françoise Mechinaud; Norbert Vey; Irène Philip; David Liens; Yann Godfrin; Dominique Rigal; Yves Bertrand
l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
British journal of haematology 2011;153(1):58-65.
2011: Xavier Thomas; Youcef Chelghoum
Promyelocytic sarcoma of the sternum: a case report and review of the literature.
The Korean journal of hematology 2011;46(1):52-6.
2011: Valérie Capraro; Linda Zane; Delphine Poncet; David Perol; Perrine Galia; Claude Preudhomme; Nathalie Bonnefoy-Berard; Eric Gilson; Xavier Thomas; Mohamed El-Hamri; Youcef Chelghoun; Mauricette Michallet; Eric Wattel; Franck Mortreux; David Sibon
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
Experimental hematology 2011;39(2):195-202.e2.
2011: Mathilde Hunault-Berger; Thibaut Leguay; Xavier Thomas; Ollivier Legrand; Françoise Huguet; Caroline Bonmati; Martine Escoffre-Barbe; Laurence Legros; Pascal Turlure; Patrice Chevallier; Fabrice Larosa; Frederic Garban; Oumedaly Reman; Philippe Rousselot; Nathalie Dhédin; André Delannoy; Marina Lafage-Pochitaloff; Marie Christine Béné; Norbert Ifrah; Hervé Dombret
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Haematologica 2011;96(2):245-52.
2010: Xavier Thomas; Giovanna Cannas
Leukemia stem cells and new strategies to overcome resistance to therapy.
Current stem cell research & therapy 2010;5(3):277-86.
2010: Nicolas Boissel; Olivier Nibourel; Aline Renneville; Claude Gardin; Oumedaly Reman; Nathalie Contentin; Dominique Bordessoule; Cécile Pautas; Thierry de Revel; Bruno Quesnel; Pascal Huchette; Noël Philippe; Sandrine Geffroy; Christine Terre; Xavier Thomas; Sylvie Castaigne; Hervé Dombret; Claude Preudhomme
Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3717-23.
2010: Olfa Derbel; Giovanna Cannas; Quoc-Hung Le; Mohamed Elhamri; Youcef Chelghoum; Emmanuelle Nicolas-Virelizier; Franck E Nicolini; Jacques Troncy; Fiorenza Barraco; Mauricette Michallet; Xavier Thomas
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.
Hematology (Amsterdam, Netherlands) 2010;15(3):125-31.
2010: Xavier Thomas; Emmanuel Raffoux; Aline Renneville; Cecile Pautas; Stephane de Botton; Christine Terre; Claude Gardin; Sandrine Hayette; Claude Preudhomme; Hervé Dombret
Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study.
Cancer 2010;116(7):1725-32.
2010: Lionel Adès; Agnès Guerci; Emmanuel Raffoux; M Sanz; Patrice Chevallier; Simona Lapusan; Christian Recher; Xavier Thomas; C Rayon; Sylvie Castaigne; Olivier Tournilhac; Stéphane de Botton; Norbert Ifrah; Jean-Yves Cahn; Eric Solary; Claude Gardin; Nathalie Fegeux; Dominique Bordessoule; Augustin Ferrant; Sandrine Meyer-Monard; Norbert Vey; Hervé Dombret; Laurent Degos; Sylvie Chevret; Pierre Fenaux
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.
Blood 2010;115(9):1690-6.
2010: Cecile Pautas; Fatiha Merabet; Xavier Thomas; Emmanuel Raffoux; Claude Gardin; Selim Corm; Jean-Henri Bourhis; Oumedaly Reman; Pascal Turlure; Nathalie Contentin; Thierry de Revel; Philippe Rousselot; Claude Preudhomme; Dominique Bordessoule; Pierre Fenaux; Christine Terré; Mauricette Michallet; Hervé Dombret; Sylvie Chevret; Sylvie Castaigne
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):808-14.
2010: Sébastien Maury; Françoise Huguet; Thibaut Leguay; Francis Lacombe; Marc Maynadié; Sandrine Girard; Adrienne de Labarthe; Emilienne Kuhlein; Emmanuel Raffoux; Xavier Thomas; Patrice Chevallier; Agnès Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Philippe Rousselot; Elizabeth Macintyre; Norbert Ifrah; Hervé Dombret; Marie-Christine Béné
Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Haematologica 2010;95(2):324-8.
2009: Xavier Thomas; Emmanuel Raffoux; Mohamed Elhamri; Ida Lobe; Giovanna Cannas; Hervé Dombret
Clofarabine for the treatment of adult acute myeloid leukemia.
Future oncology (London, England) 2009;5(8):1197-210.
2009: Aline Renneville; Nicolas Boissel; Virginie Zurawski; Laura Llopis; Valéria Biggio; Olivier Nibourel; Noël Philippe; Xavier Thomas; Hervé Dombret; Claude Preudhomme
Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Cancer 2009;115(16):3719-27.
2009: Xavier Thomas; Jacques Troncy
Arsenic: a beneficial therapeutic poison - a historical overview.
Adler Museum bulletin 2009;35(1):3-13.
2009: Aline Renneville; Nicolas Boissel; Nathalie Gachard; Dina Naguib; Christian Bastard; Stéphane de Botton; Olivier Nibourel; Cécile Pautas; Oumedaly Reman; Xavier Thomas; Claude Gardin; Christine Terré; Sylvie Castaigne; Claude Preudhomme; Hervé Dombret
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.
Blood 2009;113(21):5090-3.
2009: Vahid Asnafi; Agnès Buzyn; Sandrine Le Noir; Frédéric Baleydier; Arnauld Simon; Kheira Beldjord; Oumedaly Reman; Francis Witz; Thierry Fagot; Emmanuelle Tavernier; Pascal Turlure; Thibaut Leguay; Francoise Huguet; Jean-Paul Vernant; Francis Daniel; Marie-Christine Béné; Norbert Ifrah; Xavier Thomas; Hervé Dombret; Elizabeth Macintyre
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Blood 2009;113(17):3918-24.
2009: Francoise Huguet; Thibaut Leguay; Emmanuel Raffoux; Xavier Thomas; Kheira Beldjord; Eric Delabesse; Patrice Chevallier; Agnès Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Marina Lafage-Pochitaloff; Agnès Chassevent; Véronique Lhéritier; Elizabeth Macintyre; Marie-Christine Béné; Norbert Ifrah; Hervé Dombret
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):911-8.
2009: Xavier Thomas; Fiorenza Barraco; Youcef Chelghoum; Jacques Troncy
The rationale and use of hypomethylation agents in adult acute myeloid leukemia.
Expert opinion on drug discovery 2009;4(2):195-205.
2009: Xavier Thomas
Chemotherapy of acute leukemia in adults.
Expert opinion on pharmacotherapy 2009;10(2):221-37.
2008: Jean-Valère Malfuson; Anne Etienne; Pascal Turlure; Thierry de Revel; Xavier Thomas; Nathalie Contentin; Christine Terré; Sophie Rigaudeau; Dominique Bordessoule; Norbert Vey; Claude Gardin; Hervé Dombret
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
Haematologica 2008;93(12):1806-13.
2008: Xavier Thomas; Quoc-Hung Le
Central nervous system involvement in adult acute lymphoblastic leukemia.
Hematology (Amsterdam, Netherlands) 2008;13(5):293-302.
2008: Xavier Thomas; Laura Pavan; Quoc-Hung Le
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Bulletin du cancer 2008;95(7):707-15.
2008: Xavier Thomas; Hervé Dombret
Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Leukemia & lymphoma 2008;49(7):1246-54.
2008: Xavier Thomas
New emerging applications of molgramostim in acute myeloid leukaemia.
Expert opinion on drug metabolism & toxicology 2008;4(6):795-806.
2008: Xavier Thomas
The role of timed sequential chemotherapy in adult acute myelogenous leukemia.
Current hematologic malignancy reports 2008;3(2):89-95.
2008: Claudiu Plesa; Youcef Chelghoum; Adriana Plesa; Mohamed Elhamri; Isabelle Tigaud; Mauricette Michallet; Charles Dumontet; Xavier Thomas
Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Cancer 2008;112(3):572-80.
2008: Lionel Adès; Miguel A Sanz; Sylvie Chevret; Pau Montesinos; Patrice Chevallier; Emmanuel Raffoux; Edo Vellenga; Agnès Guerci; Arnaud Pigneux; Francoise Huguet; C Rayon; Anne-Marie Stoppa; Javier de la Serna; Jean-Yves Cahn; Sandrine Meyer-Monard; Thomas Pabst; Xavier Thomas; Stéphane de Botton; Ricardo Parody; Juan Bergua; Thierry Lamy; Anne Vekhoff; Silvia Negri; Norbert Ifrah; Hervé Dombret; Augustin Ferrant; Dominique Bron; Laurent Degos; Pierre Fenaux
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
Blood 2008;111(3):1078-84.
2007: Emmanuelle Tavernier; Quoc-Hung Le; Stéphane de Botton; Nathalie Dhédin; Claude-Eric Bulabois; Oumedaly Reman; Norbert Vey; Véronique Lhéritier; Hervé Dombret; Xavier Thomas
Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Cancer 2007;110(12):2747-55.
2007: Xavier Thomas; Mohamed Elhamri
Tipifarnib in the treatment of acute myeloid leukemia.
Biologics : targets & therapy 2007;1(4):415-24.
2007: Xavier Thomas
[Acute lymphoblastic leukemia with Philadelphia chromosome: treatment with kinase inhibitors].
Bulletin du cancer 2007;94(10):871-80.
2007: Julie Bergeron; Emmanuelle Clappier; Isabelle Radford; Agnès Buzyn; Corinne Millien; Gwendoline Soler; Paola Ballerini; Xavier Thomas; Jean Soulier; Hervé Dombret; Elizabeth Macintyre; Vahid Asnafi
Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
Blood 2007;110(7):2324-30.
2007: Thomas Bénet; Marie-Christine Nicolle; Anne Thiebaut; Marie-Antoinette Piens; Franck E Nicolini; Xavier Thomas; Stéphane Picot; Mauricette Michallet; Philippe Vanhems
Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(6):682-6.
2007: Emmanuelle Tavernier; Jean-Michel Boiron; Francoise Huguet; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Jean-Paul Vernant; Hervé Dombret; Xavier Thomas
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia 2007;21(9):1907-14.
2007: Claude Gardin; Pascal Turlure; Thierry Fagot; Xavier Thomas; Christine Terre; Nathalie Contentin; Emmanuel Raffoux; Stéphane de Botton; Cécile Pautas; Oumedaly Reman; Jean-Henri Bourhis; Pierre Fenaux; Sylvie Castaigne; Mauricette Michallet; Claude Preudhomme; Thierry de Revel; Dominique Bordessoule; Hervé Dombret
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
Blood 2007;109(12):5129-35.
2007: Quoc-Hung Le; Xavier Thomas; rené ecochard; Jean Iwaz; Véronique Lhéritier; Mauricette Michallet; Denis Fiere
Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
Cancer 2007;109(10):2058-67.
2007: Xavier Thomas; Stefan Suciu; Bernard Rio; Giuseppe Leone; Giorgio Broccia; George Fillet; Ulrich Jehn; Walter Feremans; Giovanna Meloni; Marco Vignetti; Theo de Witte; Sergio Amadori
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
Haematologica 2007;92(3):389-96.
2007: Xavier Thomas; Emmanuel Raffoux; S de Botton; Cécile Pautas; Philippe Arnaud; Thierry de Revel; Oumedaly Reman; Christine Terré; B Corront; Claude Gardin; Quoc-Hung Le; Bruno Quesnel; Catherine Cordonnier; Jean-Henri Bourhis; Mohamed Elhamri; Pierre Fenaux; Claude Preudhomme; Mauricette Michallet; Sylvie Castaigne; Hervé Dombret
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Leukemia 2007;21(3):453-61.
2007: Adrienne de Labarthe; Philippe Rousselot; Françoise Huguet-Rigal; Eric Delabesse; Francis Witz; Sébastien Maury; Delphine Réa; Jean-Michel Cayuela; Marie-Christine Vekemans; Oumedaly Reman; Agnès Buzyn; Arnaud Pigneux; Martine Escoffre; Yves Chalandon; Elizabeth Macintyre; Véronique Lhéritier; Jean-Paul Vernant; Xavier Thomas; Norbert Ifrah; Hervé Dombret
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.
Blood 2007;109(4):1408-13.
2007: Xavier Thomas; Hervé Dombret
Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia.
Hematology (Amsterdam, Netherlands) 2007;12(1):15-28.
2007: Anne-Laure Taksin; Ollivier Legrand; Emmanuel Raffoux; Thierry de Revel; Xavier Thomas; Nathalie Contentin; Reda Bouabdallah; Cécile Pautas; Pascal Turlure; Oumedaly Reman; Claude Gardin; Bruno Varet; Stéphane de Botton; F Pousset; H Farhat; Sylvie Chevret; Hervé Dombret; Sylvie Castaigne
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
Leukemia 2007;21(1):66-71.
2007: Nabaz Jaff; Youcef Chelghoum; Mohamed Elhamri; Isabelle Tigaud; Mauricette Michallet; Xavier Thomas
Trisomy 8 as sole anomaly or with other clonal aberrations in acute myeloid leukemia: impact on clinical presentation and outcome.
Leukemia research 2007;31(1):67-73.
2006: Lionel Adès; Sylvie Chevret; Emmanuel Raffoux; Stéphane de Botton; Agnès Guerci; Arnaud Pigneux; Anne-Marie Stoppa; Thierry Lamy; Françoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; Frédéric Maloisel; Eric DECONINCK; Augustin Ferrant; Xavier Thomas; Nathalie Fegueux; Christine Chomienne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5703-10.
2006: C Picard; Sandrine Hayette; Chrystèle Bilhou-Nabera; Jean-Michel Cayuela; Eric Delabesse; N Frenoy; Claude Preudhomme; M Dupont; Christian Bastard; Dominique Bories; Jean-Luc Vaerman; Frédéric Davi; Nicole Dastugue; Sophie Raynaud; Marina Lafage; Frederic Deschaseaux; Thierry Fest; M P Gaub; Véronique Lhéritier; Xavier Thomas; Christiane Charrin; Claude Boucheix; Hervé Dombret; Elizabeth Macintyre; Denis Fière; Jean Gabert
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.
Leukemia 2006;20(12):2178-81.
2006: Quoc-Hung Le; Xavier Thomas; rené ecochard; Jean Iwaz; Véronique Lhéritier; Mauricette Michallet; Denis Fiere
Initial and late prognostic factors to predict survival in adult acute lymphoblastic leukaemia.
European journal of haematology 2006;77(6):471-9.
2006: Ulrich Jehn; Stefan Suciu; Xavier Thomas; F Lefrère; Petra Muus; Zwi Berneman; Jean-Pierre Marie; F Adamo; George Fillet; Francesco Nobile; Francesco Ricciuti; Giuseppe Leone; V Rizzoli; Marco Montanaro; Filip Beeldens; Paola Fazi; Franco Mandelli; Rein Willemze; Theo de Witte; Sergio Amadori
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial.
Leukemia 2006;20(10):1723-30.
2006: André Delannoy; Eric Delabesse; Véronique Lhéritier; Sylvie Castaigne; Françoise Rigal-Huguet; Emmanuel Raffoux; Frédéric Garban; Ollivier Legrand; Serge Bologna; V Dubruille; Pascal Turlure; Oumedaly Reman; Martine Delain; Françoise Isnard; Diane Coso; Pascale Raby; Agnès Buzyn; S Caillères; S Darre; Cécile Fohrer; Anne Sonet; Chrystèle Bilhou-Nabera; marie bene; Hervé Dombret; Patrice Berthaud; Xavier Thomas
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.
Leukemia 2006;20(9):1526-32.
2006: Xavier Thomas; Arnaud Pigneux; Emmanuel Raffoux; Francoise Huguet; Denis Caillot; Pierre Fenaux
Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
Haematologica 2006;91(7):996-7.
2006: Anne-Sophie Michallet; Youcef Chelghoum; Anne Thiebaut; Quoc-Hung Le; Thomas Prebet; Emmanuelle Tavernier; Daciana Antal; Franck E Nicolini; Jacques Troncy; Mohamed Elhamri; Mauricette Michallet; Xavier Thomas
Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience.
Hematology (Amsterdam, Netherlands) 2006;11(3):157-64.
2006: Nicolas Boissel; Hugues Leroy; Benoît Brethon; Noël Philippe; Stéphane de Botton; Anne Auvrignon; Emmanuel Raffoux; Thierry Leblanc; Xavier Thomas; Olivier Hermine; Bruno Quesnel; André Baruchel; Guy Leverger; Hervé Dombret; Claude Preudhomme
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).
Leukemia 2006;20(6):965-70.
2006: C Kelaidi; Lionel Ades; Sylvie Chevret; M Sanz; Agnès Guerci; Xavier Thomas; Stéphane de Botton; Emmanuel Raffoux; C Rayon; Nathalie Fegueux; Dominique Bordessoule; Françoise Rigal-Huguet; H Link; Anne-Marie Stoppa; Anne Vekhoff; Sandrine Meyer-Monard; Sylvie Castaigne; Hervé Dombret; Laurent Degos; Pierre Fenaux
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
Leukemia 2006;20(5):905-7.
2006: Sophie Ducastelle; Lionel Adès; Claude Gardin; Hervé Dombret; Thomas Prébet; Eric DECONINCK; Bernard Rio; Xavier Thomas; Stephan Debotton; Agnès Guerci; Nicole Gratecos; Aspasia Stamatoullas; Nathalie Fegueux; François Dreyfus; Pierre Fenaux; Eric Wattel
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Haematologica 2006;91(3):373-6.
2006: Delphine Rea; Laurence Legros; Emmanuel Raffoux; Xavier Thomas; Pascal Turlure; Sébastien Maury; Brigitte Dupriez; Arnaud Pigneux; B Choufi; Oumedaly Reman; D Stéphane; Bruno Royer; Magda Vigier; M Ojeda-Uribe; Christian Recher; Hervé Dombret; Francoise Huguet; Philippe Rousselot
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.
Leukemia 2006;20(3):400-3.
2006: Nathalie Dhédin; Hervé Dombret; Xavier Thomas; Véronique Lhéritier; Jean-Michel Boiron; Françoise Rigal-Huguet; Norbert Vey; Mathieu Kuentz; Oumedaly Reman; Francis Witz; André Delannoy; Tibor J Kovacsovics; Kenneth F Bradstock; Christiane Charrin; Claude Boucheix; Jean Gabert; Didier Blaise; Denis Fière; Jean-Paul Vernant
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials.
Leukemia 2006;20(2):336-44.
2006: Franck E Nicolini; Kaddour Chabane; Jean-Michel Cayuela; Philippe Rousselot; Xavier Thomas; Sandrine Hayette
The role of the K247R substitution in the ABL tyrosine kinase domain in sensitivity to imatinib.
Haematologica 2006;91(1):137-8.
2006: Stéphane de Botton; M A Sanz; Sylvie Chevret; Hervé Dombret; G Martin; Xavier Thomas; J D Mediavilla; Christian Recher; Lionel Ades; Bruno Quesnel; P Brault; Martin Fey; H Wandt; D Machover; Agnès Guerci; Frédéric Maloisel; Anne-Marie Stoppa; C Rayon; J M Ribera; Christine Chomienne; Laurent Degos; Pierre Fenaux
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Leukemia 2006;20(1):35-41.
2005: Carlos M Galmarini; Emeline Cros; Xavier Thomas; Lars Petter Jordheim; Charles Dumontet
The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia.
Haematologica 2005;90(12):1699-701.
2005: Nicolas Boissel; Aline Renneville; Valeria Biggio; Noël Philippe; Xavier Thomas; Jean-Michel Cayuela; Christine Terre; Isabelle Tigaud; Sylvie Castaigne; Emmanuel Raffoux; Stéphane de Botton; Pierre Fenaux; Hervé Dombret; Claude Preudhomme
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Blood 2005;106(10):3618-20.
2005: Xavier Thomas; Lydia Campos; Christiane Mounier; Jérome Cornillon; Pascale Flandrin; Quoc-Hung Le; Simone Piselli; Denis Guyotat
Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia.
Leukemia research 2005;29(9):1049-58.
2005: Xavier Thomas
Emerging drugs for adult acute lymphoblastic leukaemia.
Expert opinion on emerging drugs 2005;10(3):591-617.
2005: Xavier Thomas; Qh Le; S de Botton; Emmanuel Raffoux; Youcef Chelghoum; Cécile Pautas; François Dreyfus; Nathalie Dhedin; Anne Vekhoff; Jacques Troncy; Arnaud Pigneux; T de Revel; Oumedaly Reman; Philippe Travade; Anne Thiebaut; Agnès Guerci; Mohamed Elhamri; Pierre Fenaux; Hervé Dombret; Mauricette Michallet
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
Leukemia & lymphoma 2005;46(7):1007-16.
2005: Youcef Chelghoum; Norbert Vey; Emmanuel Raffoux; Francoise Huguet; Arnaud Pigneux; Brigitte Witz; Cécile Pautas; Stéphane de Botton; Denis Guyotat; Bruno Lioure; Nathalie Fegueux; Frédéric Garban; Hussam Saad; Xavier Thomas
Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.
Cancer 2005;104(1):110-7.
2005: C Callens; Sylvie Chevret; Jean-Michel Cayuela; Bruno Cassinat; Emmanuel Raffoux; Stéphane de Botton; Xavier Thomas; Agnès Guerci; Nathalie Fegueux; Arnaud Pigneux; Anne-Marie Stoppa; Thierry Lamy; Françoise Rigal-Huguet; Anne Vekhoff; Sandrine Meyer-Monard; A Ferrand; M Sanz; Christine Chomienne; Pierre Fenaux; Hervé Dombret
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Leukemia 2005;19(7):1153-60.
2005: Sergio Amadori; Stefan Suciu; Ulrich Jehn; Roberto Stasi; Xavier Thomas; Jean-Pierre Marie; Petra Muus; Francois Lefrère; Zwi Berneman; George Fillet; Claudio Denzlinger; Rein Willemze; Pietro Leoni; Giuseppe Leone; Marco Casini; Francesco Ricciuti; Marco Vignetti; Filip Beeldens; Franco Mandelli; Theo de Witte
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.
Blood 2005;106(1):27-34.
2005: Xavier Thomas; Lydia Campos; Quoc-Hung Le; Denis Guyotat
Heat shock proteins and acute leukemias.
Hematology (Amsterdam, Netherlands) 2005;10(3):225-35.
2005: Xavier Thomas; Mohamed Elhamri; Youcef Chelghoum; Oumedaly Reman; Philippe Arnaud; Emmanuel Raffoux; Quoc-Hung Le; Emmanuelle Tavernier; Hervé Dombret; Mauricette Michallet
Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
Annals of hematology 2005;84(6):376-82.
2005: Vahid Asnafi; Agnès Buzyn; Xavier Thomas; Francoise Huguet; Norbert Vey; Jean-Michel Boiron; Oumedaly Reman; Jean-Michel Cayuela; Veronique Lheritier; Jean-Paul Vernant; Denis Fiere; Elizabeth Macintyre; Hervé Dombret
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
Blood 2005;105(8):3072-8.
2005: Adrienne de Labarthe; Cécile Pautas; Xavier Thomas; Stéphane de Botton; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Christian Bastard; Claude Preudhomme; Mauricette Michallet; Pierre Fenaux; Jean-Noël Bastie; Gérard Socié; Catherine Cordonnier; Hervé Dombret
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Bone marrow transplantation 2005;35(8):767-73.
2005: Xavier Thomas; Mohamed Elhamri
[Farnesyltransferase inhibitors: preliminary results in acute myeloid leukemia].
Bulletin du cancer 2005;92(3):227-38.
2005: Anne-Sophie Michallet; Franck E Nicolini; S Fürst; Quoc-Hung Le; Valérie Dubois; Sandrine Hayette; Jean-Paul Bourgeot; Jean-Pierre Tremisi; Xavier Thomas; Lucette Gebuhrer; Mauricette Michallet
Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).
Bone marrow transplantation 2005;35(6):601-8.
2005: Anne-Sophie Michallet; Sabine Fürst; Quoc-Hung Le; Valérie Dubois; Aline Praire; Franck E Nicolini; Xavier Thomas; Hanadi Rafii; Lucette Gebuhrer; Mauricette Michallet
Impact of chimaerism analysis and kinetics on allogeneic haematopoietic stem cell transplantation outcome after conventional and reduced-intensity conditioning regimens.
British journal of haematology 2005;128(5):676-89.
2005: Lionel Ades; Sylvie Chevret; Stéphane de Botton; Xavier Thomas; Hervé Dombret; B Beve; M Sanz; Agnès Guerci; JS Miguel; J Dela Serna; C Garo; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.
Leukemia 2005;19(2):230-3.
2005: Stéphane de Botton; A Fawaz; Sylvie Chevret; Hervé Dombret; Xavier Thomas; M Sanz; Agnès Guerci; Jesús San Miguel; Javier de la Serna; Anne-Marie Stoppa; Oumedaly Reman; A Stamatoulas; Martin Fey; Jean-Yves Cahn; Jean-Jacques Sotto; Jean-Henri Bourhis; A Parry; Christine Chomienne; Laurent Degos; Pierre Fenaux
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):120-6.
2004: Xavier Thomas; Jean-Michel Boiron; Francoise Huguet; Hervé Dombret; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Jean-Paul Vernant; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Denis Fiere
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4075-86.
2004: Sylvie Castaigne; Sylvie Chevret; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Marc Simon; Brigitte Dupriez; Michel Renoux; Maud Janvier; Jean-Michel Micléa; Xavier Thomas; Christian Bastard; Claude Preudhomme; Francis Bauters; Laurent Degos; Hervé Dombret
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Christiane Charrin; Xavier Thomas; Martine Ffrench; Quoc-Hung Le; Joris Andrieux; Marie-Joëlle Mozziconacci; Jean-Luc Laï; Chrystèle Bilhou-Nabera; Lucienne Michaux; Alain BERNHEIM; Christian Bastard; Hossein Mossafa; Christine Perot; Odile Maarek; Claude Boucheix; Véronique Lheritier; André Delannoy; Denis Fière; Nicole Dastugue
A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL).
Blood 2004;104(8):2444-51.
2004: Roch Houot; Emmanuelle Tavernier; Quoc-Hung Le; Véronique Lhéritier; Anne Thiebaut; Xavier Thomas
Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome.
Hematology (Amsterdam, Netherlands) 2004;9(5-6):369-76.
2004: Sandrine Hayette; Isabelle Tigaud; Xavier Thomas; M French; M C Perrin; Franck E Nicolini; Mauricette Michallet; Jean-Pierre Magaud
Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report.
Leukemia 2004;18(10):1735-6.
2004: Xavier Thomas; Emmanuelle Tavernier; Quoc-Hung Le
[Acute lymphoblastic leukemia in elderly: prognosis and treatment].
Bulletin du cancer 2004;91(9):713-20.
2004: Xavier Thomas; Youcef Chelghoum
Cigarette smoking and acute leukemia.
Leukemia & lymphoma 2004;45(6):1103-9.
2004: Carlos M Galmarini; Emeline Cros; Kathryn Graham; Xavier Thomas; John R Mackey; Charles Dumontet
5'-(3')-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine.
Haematologica 2004;89(5):617-9.
2004: Xavier Thomas; Jean-Michel Boiron; Francoise Huguet; Oumedaly Reman; Laurent Sutton; Pascal Turlure; Frédéric Garban; Claude Gardin; Daniel Espinouse; Olivier Boulat; Véronique Lhéritier; Denis Fiere
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(5):384-94.
2004: Oumedaly Reman; Agnès Buzyn; Véronique Lhéritier; Francoise Huguet; Mathieu Kuentz; Aspasia Stamatoullas; André Delannoy; Nathalie Fegueux; Jean-Michel Micléa; Jean-Michel Boiron; Jean-Paul Vernant; Claude Gardin; Maurice Hacini; Michel Georges; Denis Fière; Xavier Thomas
Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):123-9.
2003: Marie-Thérèse Rubio; Nathalie Dhedin; Claude Boucheix; Jean-Henri Bourhis; Oumedaly Reman; Jean-Michel Boiron; J H Gallo; Véronique Lhéritier; Xavier Thomas; Denis Fière; Jean-Paul Vernant
Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome.
British journal of haematology 2003;123(5):842-9.
2003: D Revesz; Youcef Chelghoum; Quoc-Hung Le; Mohamed Elhamri; Mauricette Michallet; Xavier Thomas
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Annals of hematology 2003;82(11):684-90.
2003: Emmanuelle Tavernier; Xavier Thomas
Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Indian journal of cancer 2003;40(4):140-3.
2003: Xavier Thomas; Quoc-Hung Le
[Current therapeutic strategies in acute lymphoblastic leukemia in the adult].
Bulletin du cancer 2003;90(10):833-50.
2003: Xavier Thomas; Quoc-Hung Le
Prognostic factors in adult acute lymphoblastic leukemia.
Hematology (Amsterdam, Netherlands) 2003;8(4):233-42.
2003: Carlos M Galmarini; Xavier Thomas; Kathryn Graham; Assia El Jafaari; Emeline Cros; Lars Petter Jordheim; John R Mackey; Charles Dumontet
Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
British journal of haematology 2003;122(1):53-60.
2003: M Beaumont; M Sanz; P M Carli; Frédéric Maloisel; Xavier Thomas; L Detourmignies; Agnès Guerci; Nicole Gratecos; C Rayon; Jesús San Miguel; Jesús Odriozola; Jean-Yves Cahn; Francoise Huguet; A Vekhof; A Stamatoulas; Hervé Dombret; Francisco J Capote; Jordi Esteve; Anne-Marie Stoppa; Pierre Fenaux
Therapy-related acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2123-37.
2003: Nicolas Boissel; Marie-Françoise Auclerc; Véronique Lhéritier; Yves Perel; Xavier Thomas; Thierry Leblanc; Philippe Rousselot; Jean-Michel Cayuela; Jean Gabert; Nathalie Fegueux; Christophe Piguet; Françoise Huguet-Rigal; Christian Berthou; Jean-Michel Boiron; Cécile Pautas; Gérard Michel; Denis Fière; Guy Leverger; Hervé Dombret; André Baruchel
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):774-80.
2003: Emmanuelle Tavernier; Quoc-Hung Le; Mohamed Elhamri; Xavier Thomas
Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Leukemia research 2003;27(3):205-14.
2002: Claude Preudhomme; Christophe Sagot; Nicolas Boissel; Jean-Michel Cayuela; Isabelle Tigaud; Stéphane de Botton; Xavier Thomas; Emmanuel Raffoux; Charlotte Lamandin; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
Blood 2002;100(8):2717-23.
2002: Youcef Chelghoum; Catalin Danaïla; Amine Belhabri; Christiane Charrin; Quoc-Hung Le; Mauricette Michallet; Denis Fiere; Xavier Thomas
Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1621-7.
2002: Hervé Dombret; Jean Gabert; Jean-Michel Boiron; Françoise Rigal-Huguet; Didier Blaise; Xavier Thomas; André Delannoy; Agnès Buzyn; Chrystèle Bilhou-Nabera; Jean-Michel Cayuela; Pierre Fenaux; Jean-Henri Bourhis; Nathalie Fegueux; Christiane Charrin; Claude Boucheix; Véronique Lhéritier; Hélène Espérou; Elizabeth Macintyre; Jean-Paul Vernant; Denis Fière
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Blood 2002;100(7):2357-66.
2002: Xavier Thomas; Quoc-Hung Le; Catalin Danaïla; Véronique Lhéritier; Martine Ffrench
Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
Leukemia research 2002;26(10):909-18.
2002: Xavier Thomas; Quoc-Hung Le; Denis Fiere
Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.
Annals of hematology 2002;81(9):504-7.
2002: Xavier Thomas; Quoc-Hung Le
[Treatment of acute myeloid leukemias in the adult in relapse].
Bulletin du cancer 2002;89(9):795-807.
2002: Nicolas Boissel; Jean-Michel Cayuela; Claude Preudhomme; Xavier Thomas; Nathalie Grardel; Xavier Fund; Isabelle Tigaud; Emmanuel Raffoux; Philippe Rousselot; François Sigaux; Laurent Degos; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy.
Leukemia 2002;16(9):1699-704.
2002: Carlos M Galmarini; Xavier Thomas; Fabien Calvo; Philippe Rousselot; Assia El Jafaari; Emeline Cros; Charles Dumontet
Potential mechanisms of resistance to cytarabine in AML patients.
Leukemia research 2002;26(7):621-9.
2002: Sandrine Hayette; Isabelle Tigaud; Véronique Maguer-Satta; Laurent Bartholin; Xavier Thomas; Christiane Charrin; Mylène Gadoux; Jean-Pierre Magaud; Ruth Rimokh
Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia.
Blood 2002;99(12):4647-9.
2002: Carlos M Galmarini; Xavier Thomas; Fabien Calvo; Philippe Rousselot; Muriel Rabilloud; Assia El Jaffari; Emeline Cros; Charles Dumontet
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
British journal of haematology 2002;117(4):860-8.
2002: Stéphanie Nguyen; Thierry Leblanc; Pierre Fenaux; Francis Witz; Didier Blaise; Arnaud Pigneux; Xavier Thomas; Françoise Rigal-Huguet; Bruno Lioure; Anne Auvrignon; Denis Fière; Josy Reiffers; Sylvie Castaigne; Guy Leverger; Jean-Luc Harousseau; Gérard Socié; Hervé Dombret
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Blood 2002;99(10):3517-23.
2002: Amine Belhabri; Xavier Thomas; Eric Wattel; Youcef Chelghoum; Bruno Anglaret; Anne Vekhoff; Oumedaly Reman; Hervé Dombret; Nathalie Dhedin; Mauricette Michallet; Denis Fière; Eric Archimbaud
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(1):49-55.
2002: Christiane Charrin; Amine Belhabri; Danielle Treille-Ritouet; Gianina Theuil; Jean-Pierre Magaud; Denis Fiere; Xavier Thomas
Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(1):21-31.
2002: André Delannoy; Bruno Cazin; Xavier Thomas; Reda Bouabdallah; Jean-Michel Boiron; F Huguet; Nicole Straetmans; H Zérazhi; Jean-Paul Vernant; Hervé Dombret; Chrystèle Bilhou-Nabera; Christiane Charrin; Claude Boucheix; Catherine Sebban; Véronique Lhéritier; Denis Fière
Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission.
Leukemia & lymphoma 2002;43(1):75-81.
2001: Xavier Thomas; Catalin Danaïla; Quoc-Hung Le; Catherine Sebban; Jacques Troncy; Christiane Charrin; Véronique Lhéritier; Mauricette Michallet; Jean-Pierre Magaud; Denis Fiere
Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
Leukemia 2001;15(12):1811-22.
2001: E Voog; Quoc-Hung Le; I Philip; B Benetaib; Mauricette Michallet; Denis Fiere; Xavier Thomas
Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone.
Annals of hematology 2001;80(10):584-91.
2001: Carlos M Galmarini; Kathryn Graham; Xavier Thomas; Fabien Calvo; Philippe Rousselot; Assia El Jafaari; Emeline Cros; John R Mackey; Charles Dumontet
Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia.
Blood 2001;98(6):1922-6.
2001: Mauricette Michallet; Karin Bilger; Frédéric Garban; Michel Attal; A Huyn; Didier Blaise; Noël Milpied; Philippe Moreau; Pierre Bordigoni; Mathieu Kuentz; Alain Sadoun; Jean-Yves Cahn; Gérard Socié; Xavier Thomas; P Arnaud; N Raus; Véronique Lhéritier; Arnaud Pigneux; Jean-Michel Boiron
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3340-9.
2001: Xavier Thomas; N Olteanu; Christiane Charrin; Véronique Lhéritier; Jean-Pierre Magaud; Denis Fiere
Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
American journal of hematology 2001;67(2):73-83.
2001: A Colita; Amine Belhabri; Youcef Chelghoum; Christiane Charrin; Denis Fiere; Xavier Thomas
Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):451-5.
2000: Mauricette Michallet; A Thiébaut; Irène Philip; Christiane Charrin; C Vigouroux; Xavier Thomas; Karin Bilger; Amine Belhabri; Denis Guyotat; B Corront; B Salles; C Dumontet; Pierre-Yves Péaud; Jean-Pierre Vilque; A Devidas; Denis Fière
Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha.
Leukemia 2000;14(12):2064-9.
2000: Anne Thiebaut; Jean-Paul Vernant; Laurent Degos; Francoise Huguet; Josy Reiffers; Catherine Sebban; E Lepage; Xavier Thomas; Denis Fière
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.
Hematology/oncology clinics of North America 2000;14(6):1353-66, x.
2000: Stéphane de Botton; Sylvie Chevret; M Sanz; Hervé Dombret; Xavier Thomas; Agnès Guerci; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; Pascale Cony-Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; Jesús San Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; K Geiser; Urs Hess; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Christine Chomienne; Laurent Degos; Pierre Fenaux
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
British journal of haematology 2000;111(3):801-6.
2000: Xavier Thomas; N Cambier; Anne-Laure Taksin; Oumedaly Reman; Anne Vekhoff; Cécile Pautas; Véronique Leblond; P Soler-Michel; E Ecstein-Fraïssé; Eric Archimbaud
Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia.
Leukemia research 2000;24(11):957-63.
2000: Xavier Thomas; Jacques Troncy; Amine Belhabri; Anne Thiebaut; N Bouheddou; Mauricette Michallet; J Fleurette; C Pivot; Denis Fiere; Eric Archimbaud
[Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
Presse médicale (Paris, France : 1983) 2000;29(32):1745-51.
2000: A Thiébaut; Xavier Thomas; Amine Belhabri; Bruno Anglaret; Eric Archimbaud
Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Annals of hematology 2000;79(9):501-6.
2000: Pierre Fenaux; Sylvie Chevret; Agnès Guerci; Nathalie Fegueux; Hervé Dombret; Xavier Thomas; M Sanz; H Link; Frédéric Maloisel; Claude Gardin; Dominique Bordessoule; Anne-Marie Stoppa; Alain Sadoun; P Muus; H Wandt; P Mineur; J A Whittaker; Martin Fey; Marie-Thérèse Daniel; Sylvie Castaigne; Laurent Degos
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.
Leukemia 2000;14(8):1371-7.
2000: Xavier Thomas; Hervé Dombret; Catherine Cordonnier; Arnaud Pigneux; Claude Gardin; Agnès Guerci; Anne Vekhoff; Alain Sadoun; Aspasia Stamatoullas; Nathalie Fegueux; Frédéric Maloisel; Jean-Yves Cahn; Oumedaly Reman; Nicole Gratecos; Christian Berthou; Francoise Huguet; P Kotoucek; Philippe Travade; Agnès Buzyn; Thierry de Revel; Jean-Pierre Vilque; P Naccache; Christine Chomienne; Laurent Degos; Pierre Fenaux
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Leukemia 2000;14(6):1006-13.
2000: L Pérard; Xavier Thomas; H Jaumain; G Theuil; Monique Bret; B Coronel; Christiane Charrin; P Boulétreau
T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn's disease and lipoid nephrosis.
Annals of hematology 2000;79(4):222-5.
1999: Amine Belhabri; Xavier Thomas; Jacques Troncy; David Assouline; Mauricette Michallet; Eric Wattel; Jean-Dominique Tigaud; M Blanc; Denis Fière; Eric Archimbaud
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study.
Leukemia & lymphoma 1999;36(1-2):45-55.
1999: Xavier Thomas; Pierre Fenaux; Hervé Dombret; S Delair; François Dreyfus; Hervé Tilly; Anne Vekhoff; Pascale Cony-Makhoul; Véronique Leblond; Xavier Troussard; Catherine Cordonnier; Thierry de Revel; M Simon; Franck E Nicolini; Anne-Marie Stoppa; Maud Janvier; Dominique Bordessoule; Philippe Rousselot; Martine Ffrench; Jean-Pierre Marie; Eric Archimbaud
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
Leukemia 1999;13(8):1214-20.
1999: Eric Archimbaud; Ulrich Jehn; Xavier Thomas; F De Cataldo; George Fillet; Amine Belhabri; P Y Peaud; C Martin; Sergio Amadori; Rein Willemze
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
Leukemia 1999;13(6):843-9.
1999: Xavier Thomas; Bruno Anglaret
[Cell adhesion molecules: expression and function in acute myeloid leukemia].
Bulletin du cancer 1999;86(3):265-77.
1999: Xavier Thomas; M H Teillon; Amine Belhabri; Ruth Rimokh; Denis Fiere; Jean-Pierre Magaud; Eric Archimbaud
Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission.
Hematology and cell therapy 1999;41(1):19-26.
1998: Xavier Thomas; Bruno Anglaret; Jean-Pierre Magaud; Joshua Epstein; Eric Archimbaud
Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
Leukemia & lymphoma 1998;32(1-2):107-19.
1998: Eric Archimbaud; Xavier Thomas
Thrombopoietic factors potentially useful in the treatment of acute leukemia.
Leukemia research 1998;22(12):1155-64.
1998: Xavier Thomas; Bruno Anglaret; M Bailly; O Maritaz; Jean-Pierre Magaud; Eric Archimbaud
Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression.
Leukemia research 1998;22(10):953-60.
1998: Xavier Thomas; Denis Fiere; Eric Archimbaud
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
Leukemia 1998;12(9):1503-6.
1998: Xavier Thomas; Anne Thiebaut; N Olteanu; Catalin Danaïla; Christiane Charrin; Eric Archimbaud; Denis Fiere
Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Hematology and cell therapy 1998;40(3):119-28.
1998: Xavier Thomas; Bruno Anglaret; Lydia Campos; Anne Thiebaut; O Sabido; M Bailly; Eric Archimbaud
Expression of beta1-integrins and pseudo-immunoglobulins on acute promyelocytic leukemia cells and its modifications during in vitro differentiation.
Leukemia research 1998;22(1):61-8.
1998: Xavier Thomas; Bruno Anglaret; P Adeleine; O Maritaz; M Bailly; Denis Fiere; Eric Archimbaud
Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.
Leukemia & lymphoma 1998;28(3-4):343-53.
1998: Eric Archimbaud; Christiane Charrin; Jean-Pierre Magaud; Lydia Campos; Xavier Thomas; Denis Fière; Ruth Rimokh
Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Leukemia 1998;12(1):25-33.
1997: Xavier Thomas; Anne Thiebaut; Denis Fière
[Acute lymphoblastic leukemia (adults and children). Diagnosis, course].
La Revue du praticien 1997;47(20):2297-304.
1997: Xavier Thomas; Bruno Anglaret; Anne Thiebaut; Amine Belhabri; Danielle Treille-Ritouet; Denis Fiere; Eric Archimbaud
Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy.
Annals of hematology 1997;75(5-6):195-200.
1997: Sandrine Hayette; Xavier Thomas; Y Bertrand; Isabelle Tigaud; Mary Callanan; Anne Thiebaut; Christiane Charrin; Eric Archimbaud; Jean-Pierre Magaud; Ruth Rimokh
Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Leukemia 1997;11(10):1696-9.
1997: Xavier Thomas; Eric Archimbaud
Mitoxantrone in the treatment of acute myelogenous leukemia: a review.
Hematology and cell therapy 1997;39(4):63-74.
1997: Xavier Thomas; C Hirschauer; Jacques Troncy; David Assouline; MO Joly; Denis Fiere; Eric Archimbaud
Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome.
Leukemia & lymphoma 1997;24(3-4):291-300.
1996: Xavier Thomas; Bruno Anglaret; D Treille-Ritouet; Y Bastion; Denis Fiere; Eric Archimbaud
Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia.
Annals of hematology 1996;73(2):95-8.
1996: Eric Archimbaud; V Leblond; Pierre Fenaux; Hervé Dombret; Catherine Cordonnier; François Dreyfus; Pascale Cony-Makhoul; Hervé Tilly; X Troussard; G Auzanneau; Xavier Thomas; Martine Ffrench; J P Marie
Timed sequential chemotherapy for advanced acute myeloid leukemia.
Hematology and cell therapy 1996;38(2):161-7.
1995: Xavier Thomas; L Vila; Lydia Campos; O Sabido; Eric Archimbaud
Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
Leukemia & lymphoma 1995;19(3-4):295-300.
1995: L Vila; Xavier Thomas; Lydia Campos; O Sabido; Eric Archimbaud
Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics.
Experimental hematology 1995;23(6):514-8.
1995: Xavier Thomas; C Danaïla; Q K Bach; P Dufour; B Christian; B Corront; A Bosly; Y Bastion; N Gratecos; R Leblay
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
Annals of hematology 1995;70(2):65-9.
1995: Xavier Thomas; Eric Archimbaud; Christiane Charrin; Jean-Pierre Magaud; Denis Fiere
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Leukemia 1995;9(2):249-53.
1995: Eric Archimbaud; Xavier Thomas; V Leblond; Mauricette Michallet; Pierre Fenaux; Catherine Cordonnier; François Dreyfus; X Troussard; Jérôme Jaubert; Philippe Travade
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):11-8.
1994: Eric Archimbaud; Xavier Thomas; Mauricette Michallet; Jérôme Jaubert; Jacques Troncy; Denis Guyotat; Denis Fiere
Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):262-7.
1993: Eric Archimbaud; Lydia Campos; L Vila; Xavier Thomas
Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia.
Immunology letters 1993;39(1):13-5.
1992: Eric Archimbaud; Bruno Anglaret; Xavier Thomas; Y Devaux; Martine Ffrench; Catherine Sebban; Jacques Troncy; Denis Fiere
Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.
Leukemia 1992;6(8):776-9.
1992: Eric Archimbaud; Bruno Anglaret; Xavier Thomas; Jérôme Jaubert; Catherine Sebban; Denis Guyotat; Denis Fiere
Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission.
Annals of hematology 1992;65(2):71-4.
1992: Xavier Thomas; Lydia Campos; Eric Archimbaud; Z H Shi; D Treille-Ritouet; Bruno Anglaret; Denis Fiere
Surface marker expression in acute myeloid leukaemia at first relapse.
British journal of haematology 1992;81(1):40-4.
1992: Eric Archimbaud; Xavier Thomas; Lydia Campos; Jean-Pierre Magaud; J F Doré; Denis Fiere
Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.
Leukemia 1992;6(4):265-71.
1991: Y Bastion; Xavier Thomas; Pascale Felman; L Campos; Christiane Charrin; Bertrand Coiffier
High risk myelodysplastic syndrome coexistent with chronic lymphocytic leukemia for more than 9 years: inhibition of the myeloid clone by the lymphoid clone?
Leukemia 1991;5(11):1006-9.
1991: Eric Archimbaud; Denis Guyotat; J Maupas; C Ploton; A Nageotte; Y Devaux; Xavier Thomas; J Fleurette; Denis Fiere
Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
European journal of cancer (Oxford, England : 1990) 1991;27(2):174-8.
1991: Xavier Thomas; Denis Guyotat; Lydia Campos; Z H Shi; L Vila; A Ehrsam; Denis Fiere
In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.
Leukemia research 1991;15(1):29-36.
1990: Denis Guyotat; Lydia Campos; Xavier Thomas; L Vila; Z H Shi; Christiane Charrin; O Gentilhomme; Denis Fiere
Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns.
American journal of hematology 1990;34(1):26-31.
1990: Xavier Thomas; Lydia Campos; S Bonnier; Jacques Troncy; Denis Guyotat; Denis Fière
Response of hematopoietic precursor cells to hematopoietic growth factors in the myelodysplastic syndromes.
Nouvelle revue française d'hématologie 1990;32(5):345-7.